Dr. Max Bottlinger is a specialist in bioorganic chemistry and the development of innovative chemical probes. His expertise lies in the design of functional molecules for biochemical applications and their biochemical evaluation. As a member of the Keynostic team, he is responsible for advancing the chemical technology platform and implementing it within lateral flow assays (LFAs).

Olga Sieluzycka is a biochemist specializing in NMR spectroscopy, molecule-protein interactions, and antibody technologies. At Keynostic, she focuses on developing and optimizing rapid diagnostic tests and on the analytical characterization of the underlying assay components.

Hendrik Stöwe brings experience in business management, business development, and technical sales. At Keynostic, he oversees the company’s operational activities and strategic growth, while managing collaborations with customers and industry partners.

Dr. Bhavna Rajasekaran leads the development of Keynostic’s software and image analysis platform. Her work focuses on computer vision, machine learning, and the digital interpretation of rapid diagnostic tests.